NasdaqGS:TEMLife Sciences
Tempus AI (TEM) Stock May Trade Below Fair Value Despite Mixed Checks
Tempus AI stock has fallen 22.4% year to date, yet the valuation checks point to a mixed picture rather than a clear verdict on whether the recent weakness leaves the shares cheap or still demanding.
After declining 22.4% year to date, Tempus AI is back under pressure. This puts more focus on whether the current price fairly reflects its prospects in healthcare AI and diagnostics.
The planned all stock acquisition of Personalis for about US$1.5b can support expectations of a larger role in...